Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region　― Analysis Using the National Health Insurance Database ―

Narita Noritomo, Okumura Ken, Kinjo Takahiko, Mikami Joko, Tsushima Katsuko, Takahashi Reiko, Noro Makiko, Hashimoto Ayaka, Sasaki Teiko, Takaki Misaki, Ishidoya Emiko, Narita Yurika, Imai Hideno, Ono Emiko, Tomita Hirofumi

Circulation Journal   84 ( 5 )   706 - 713   2020.4

Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice

Narita Masato, Hanada Kenji, Kawamura Yosuke, Ichikawa Hiroaki, Sakai Shuntaro, Yokono Yoshikazu, Senoo Maiko, Narita Noritomo, Shimada Michiko, Osanai Tomohiro, Okumura Ken, Tomita Hirofumi

HYPERTENSION RESEARCH   44 ( 10 )   1261 - 1273   2021.10

Incidence and Outcomes of irregular protrusion after stent implantation in patients with acute myocardial infarction: An in in vivo optical coherence tomography study

Kato T., Higuma T., Yokota T., Kudo N., Yokono Y., Senoo M., Narita N., Endo T., Nishizaki F., Shibutani S., Hanada K., Tomita H.

EUROPEAN HEART JOURNAL   40   456 - 456   2019.10

Novel Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy in the Japanese General Population

Narita Masato, Yamada Masahiro, Tsushima Michiko, Kudo Natsumi, Kato Tomo, Yokono Yoshikazu, Toyama Yuichi, Senoo Maiko, Yonekura Manabu, Narita Noritomo, Kimura Yoshihiro, Sawada Kaori, Tokuda Itoyo, Tomita Hirofumi

International Heart Journal   60 ( 3 )   679 - 687   2019.5

Involvement of β-Arrestin in Endothelin Receptor Signaling: A Possible Role in the Pathogenesis of Pulmonary Arterial Hypertension

Narita Noritomo, Hanada Kenji, Senoo Maiko, Kato Tomo, Kudo Natsumi, Yokono Yoshikazu, Tsushima Michiko, Toyama Yuichi, Narita Masato, Tomita Hirofumi

Hirosaki Medical Journal   69 ( 1-4 )   146 - 154   2019.3